[
  {
    "ts": null,
    "headline": "Weighing GoodRx After 92% Five Year Slide and Walgreens Dispute News",
    "summary": "If you’re wondering what to do with GoodRx Holdings after another tough spell for the share price, you’re definitely not alone. For investors on the sidelines or already in, the story has been one of steep declines. The stock is down 7.9% this week alone, down 16.0% year-to-date, and has experienced a staggering 92.3% drop in the last five years. These are not just numbers on a screen; they reflect changing attitudes about GoodRx’s risks and its potential to bounce back. Much of the anxiety...",
    "url": "https://finnhub.io/api/news?id=f7dbc0bfc5935c06529289698434b8525a1bddc8732ddce809af286b867b12d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760987500,
      "headline": "Weighing GoodRx After 92% Five Year Slide and Walgreens Dispute News",
      "id": 137176220,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WBA",
      "source": "Yahoo",
      "summary": "If you’re wondering what to do with GoodRx Holdings after another tough spell for the share price, you’re definitely not alone. For investors on the sidelines or already in, the story has been one of steep declines. The stock is down 7.9% this week alone, down 16.0% year-to-date, and has experienced a staggering 92.3% drop in the last five years. These are not just numbers on a screen; they reflect changing attitudes about GoodRx’s risks and its potential to bounce back. Much of the anxiety...",
      "url": "https://finnhub.io/api/news?id=f7dbc0bfc5935c06529289698434b8525a1bddc8732ddce809af286b867b12d6"
    }
  }
]